[go: up one dir, main page]

EE9700249A - Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides - Google Patents

Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides

Info

Publication number
EE9700249A
EE9700249A EE9700249A EE9700249A EE9700249A EE 9700249 A EE9700249 A EE 9700249A EE 9700249 A EE9700249 A EE 9700249A EE 9700249 A EE9700249 A EE 9700249A EE 9700249 A EE9700249 A EE 9700249A
Authority
EE
Estonia
Prior art keywords
pharmaceutical preparations
digestive enzyme
stabilizing additives
enzyme mixtures
compound lipids
Prior art date
Application number
EE9700249A
Other languages
English (en)
Other versions
EE04179B1 (et
Inventor
Galle Manfred
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of EE9700249A publication Critical patent/EE9700249A/et
Publication of EE04179B1 publication Critical patent/EE04179B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
EE9700249A 1996-08-28 1997-08-28 Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides EE04179B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19634752 1996-08-28
DE19724845A DE19724845A1 (de) 1996-08-28 1997-06-12 Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen

Publications (2)

Publication Number Publication Date
EE9700249A true EE9700249A (et) 1998-04-15
EE04179B1 EE04179B1 (et) 2003-12-15

Family

ID=26028823

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700249A EE04179B1 (et) 1996-08-28 1997-08-28 Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides

Country Status (21)

Country Link
US (1) US5993806A (et)
EP (1) EP0826375B1 (et)
JP (1) JP4593697B2 (et)
CN (1) CN1199694C (et)
AR (1) AR008807A1 (et)
AT (1) ATE284225T1 (et)
AU (1) AU722151B2 (et)
BR (1) BR9704554B1 (et)
CA (1) CA2213151C (et)
CZ (1) CZ295329B6 (et)
DE (2) DE19724845A1 (et)
DK (1) DK0826375T3 (et)
EE (1) EE04179B1 (et)
ES (1) ES2235206T3 (et)
HU (1) HUP9701437A3 (et)
NO (1) NO973940L (et)
NZ (1) NZ328616A (et)
PL (1) PL190140B1 (et)
PT (1) PT826375E (et)
SK (1) SK284639B6 (et)
TR (1) TR199700872A2 (et)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074689A (en) * 1998-03-10 2000-06-13 Immucell Corporation Colonic delivery of protein or peptide compositions
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
CN1262308C (zh) * 2000-11-02 2006-07-05 茨利安公司 得自纤毛虫类的酶作为促进消化的药物的应用
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
CN1933850B (zh) 2004-03-22 2011-01-12 索尔瓦药物有限公司 含表面活性剂的、含脂肪酶产品尤其是胰酶的口服药物组合物
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
EP1919293A4 (en) * 2005-07-20 2010-11-17 James S Brophy MODIFICATION OF PARTICLE MORPHOLOGY TO ENHANCE THE FUNCTIONALITY OF A PRODUCT
CN101233229B (zh) 2005-07-29 2013-05-01 雅培实验室有限公司 制备消毒的胰酶粉末的方法
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20110183050A1 (en) * 2006-07-20 2011-07-28 Brophy James S Modification of particle morphology to improve product functionality
US8444967B2 (en) 2010-07-09 2013-05-21 Master Supplements, Inc. Treatment including prebiotic composition for use with probiotics
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
PL2391382T3 (pl) 2009-01-29 2014-11-28 Nordmark Arzneimittel Gmbh & Co Kg Preparat farmaceutyczny zawierający lipazę pochodzenia bakteryjnego
CA2812862C (en) 2010-10-01 2018-11-20 Aptalis Pharma Limited Enteric coated, low-strength pancrelipase formulations
US10993996B2 (en) 2013-08-09 2021-05-04 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
CN106659773A (zh) * 2013-11-05 2017-05-10 阿勒根制药国际有限公司 高效的胰酶药物组合物
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
BR112017008026A2 (pt) * 2014-11-05 2018-01-23 Abbott Laboratories Gmbh processos de produção de composições com melhor perfil de segurança que possui atividade de lipase e composições apropriadas para uso farmacêutico
US20180028454A1 (en) 2015-02-04 2018-02-01 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung
DE102015114862A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
JPS58148814A (ja) * 1982-03-01 1983-09-05 Fujimoto Seiyaku Kk 消化酵素軟カプセル剤
JPS59169491A (ja) * 1983-03-15 1984-09-25 Duskin Franchise Co Ltd 酵素の安定化法
JPH0229950A (ja) * 1988-07-18 1990-01-31 Nec Corp 光ディスク
JP2679852B2 (ja) * 1989-11-29 1997-11-19 株式会社サム研究所 経口及び局所投与用生物活性蛋白組成物
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
SG49307A1 (en) * 1991-01-24 1998-05-18 Martek Corp Microbial oil mixtures and use thereof
DE4200002A1 (de) * 1992-01-02 1993-07-08 Rudolf V Dipl Chem Dr Noronha Reinigungstablette fuer die zahnprothesen
EP0719133A1 (en) * 1993-09-15 1996-07-03 Unilever Plc Skin care method and composition
JPH09125096A (ja) * 1995-10-30 1997-05-13 Koei Sangyo:Kk 液状天然油脂洗剤

Also Published As

Publication number Publication date
TR199700872A3 (tr) 1999-04-21
EP0826375A2 (de) 1998-03-04
AU3530997A (en) 1998-03-05
HK1005224A1 (en) 1998-12-31
EP0826375B1 (de) 2004-12-08
CZ295329B6 (cs) 2005-07-13
EE04179B1 (et) 2003-12-15
BR9704554B1 (pt) 2011-12-27
NO973940D0 (no) 1997-08-27
JPH1077236A (ja) 1998-03-24
DE59712108D1 (de) 2005-01-13
CN1174743A (zh) 1998-03-04
DK0826375T3 (da) 2005-01-24
TR199700872A2 (xx) 1999-04-21
CA2213151A1 (en) 1998-02-28
NZ328616A (en) 1999-01-28
ES2235206T3 (es) 2005-07-01
NO973940L (no) 1998-03-02
HU9701437D0 (en) 1997-10-28
CA2213151C (en) 2008-04-01
CZ218497A3 (cs) 1998-03-18
PL190140B1 (pl) 2005-11-30
AR008807A1 (es) 2000-02-23
AU722151B2 (en) 2000-07-20
BR9704554A (pt) 1998-09-15
PL321825A1 (en) 1998-03-02
CN1199694C (zh) 2005-05-04
SK284639B6 (sk) 2005-08-04
HUP9701437A3 (en) 2001-03-28
SK115997A3 (en) 1998-07-08
DE19724845A1 (de) 1998-03-05
ATE284225T1 (de) 2004-12-15
EP0826375A3 (de) 2002-08-14
US5993806A (en) 1999-11-30
JP4593697B2 (ja) 2010-12-08
HUP9701437A2 (hu) 1998-03-30
PT826375E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
EE9700249A (et) Liitlipiidide kasutamine stabiliseerivate lisanditena seedeensüümide segude ravimpreparaatides
DE69822839D1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
ID17863A (id) Komposisi-komposisi farmasi yang terdiri dari siklosporin
NO980126D0 (no) Plaster-formulering for perkantal administrering av fenantyl
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
ZA989740B (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
PT769965E (pt) Formulacoes aquosas de risperidona
FI954204A7 (fi) Ruiskeena annettavat liposomilääkevalmisteet
HUP0100669A3 (en) Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
EP0785772A4 (en) LYOPHILISATE OF A LIPID COMPLEX OF WATER-INSOLUBLE CAMTOTHECINS
DE69605094D1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
DE59711379D1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
FI965204L (fi) Bromelaiinin lääkekäyttö
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
BR9800440A (pt) Preparação de preparações de sabor disfarçado de derivados de quinolona antibacterianamente ativos
IL133176A0 (en) Pharmaceutical compositions of peptides having low solubility in physiological medium
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
PL332282A1 (en) Application of proteins as factors against autoimmunological diseases
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
EP0710484A3 (en) Mixture of alpha-D-glucopyranosyl- (1-6) -alpha-D glucopyranose as an anti-tumor agent
FI963263A7 (fi) Bromelaiinin lääkinnällinen käyttö
ZA977308B (en) Use of complex lipids as stabilizing-additives to pharmaceutical preparations of digestive enzyme mixtures.
FI972791A0 (fi) Orgaanisten happojen ja aminohappojen valmistus

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20060828